MedicarePartD.guide

A non-government resource built from CMS public data

COVID-19 and flu antivirals on every 2026 Tennessee Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Tennessee cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

COVID-19 and flu antivirals by 2026 Tennessee Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-106Wellcare Value Script$3.60/moS4802-147Wellcare Classic$3.70/moS4802-071Humana Value Rx Plan$37.70/moS5884-191AARP Medicare Rx Saver from UHC$63.20/moS5921-357BlueRx Essential$76.20/moS1030-006HealthSpring Extra Rx$77.50/moS5617-362HealthSpring Assurance Rx$87.20/moS5617-220SilverScript Choice$97.30/moS5601-024Humana Premier Rx Plan$108.60/moS5884-158AARP Medicare Rx Preferred from UHC$119.30/moS5921-393BlueRx Enhanced Plus$129.50/moS1030-001
Paxlovidnirmatrelvir and ritonavirTier 325%QL 60/10dTier 325%QL 30/90dTier 325%QL 30/90dTier 320%QL 60/10dTier 525%QL 30/5dTier 2$10.00QL 30/30dTier 525%QL 30/90dTier 525%QL 30/90dTier 2$7.00QL 60/180dTier 3$45.00QL 60/10dTier 531%QL 30/5dTier 2$12.00QL 30/30d
LagevriomolnupiravirNot coveredNot coveredNot coveredNot coveredTier 317%QL 40/5dNot coveredNot coveredNot coveredNot coveredNot coveredTier 317%QL 40/5dNot covered
oseltamivirgeneric TamifluTier 2$1.00QL 224/365dTier 440%QL 168/365dTier 427%QL 168/365dTier 2$0.00QL 224/365dTier 317%QL 60/30dTier 319%QL 168/365dTier 317%Tier 322%Tier 318%QL 168/365dTier 2$4.00QL 224/365dTier 317%QL 60/30dTier 3$47.00QL 168/365d
Xofluzabaloxavir marboxilNot coveredNot coveredNot coveredNot coveredTier 317%QL 2/30dTier 441%QL 4/365dTier 431%Tier 432%Not coveredNot coveredTier 317%QL 2/30dTier 442%QL 4/365d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.